Rafferty Asset Management
TNGX icon

Rafferty Asset Management’s Tango Therapeutics TNGX Stock Holding History

Rafferty Asset Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.2M Sell
104,960
-121,641
-54% -$1.69M 0.01% 588
2025
Q4 		$2.01M Buy
226,601
+81,285
+56% +$700K 0.01% 646
2025
Q3 		$1.22M Buy
+145,316
New +$983K ﹤0.01% 751
2024
Q4 		– Sell
-102,955
Closed -$793K – 1174
2024
Q3 		$793K Buy
102,955
+30,066
+41% +$287K ﹤0.01% 846
2024
Q2 		$625K Sell
72,889
-147,130
-67% -$1.14M ﹤0.01% 902
2024
Q1 		$1.75M Buy
+220,019
New +$2.36M 0.01% 717

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Rafferty Asset Management's TNGX Position: Q1 2026 in Review

Rafferty Asset Management reduced its Tango Therapeutics (TNGX) stake by 54% in Q1 2026, selling an estimated $1.69M and leaving 104,960 shares worth $2.2M. The position accounts for 0.01% of the portfolio, ranked #588.

Rafferty Asset Management first reported a position in TNGX in Q1 2024 and has held it in 6 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Rafferty Asset Management held 104,960 shares of Tango Therapeutics worth $2.2M as of Q1 2026.
  • Rafferty Asset Management sold 121,641 Tango Therapeutics shares in Q1 2026, an estimated $1.69M.
  • Tango Therapeutics made up 0.01% of Rafferty Asset Management's portfolio in Q1 2026, its #588 holding.
  • Rafferty Asset Management first reported a position in Tango Therapeutics in Q1 2024 and has held it in 6 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.